MUMBAI: Armed with interim findings from the AstraZeneca-Oxford Covid-19 vaccine trials, which showed 70% effectiveness in preventing people from becoming infected, the Pune-based Serum Institute of India (SII) is ready to look for emergency regulatory approval and hopes to get the go-ahead by the end of the year. The ‘positive’ …
Read More »